Millennium Pharmaceuticals, Inc.

Millennium was founded in 1993 as a genomics company . It has grown from that small genomics start-up into a fully-integrated biopharmaceutical company with an innovative pipeline of novel molecules.
In May 2008, Millennium was acquired by Takeda Pharmaceutical Company Limited and now it is Millennium: The Takeda Oncology Company. It continues to be an entrepreneurial culture of best and brightest talent, who passionately strive to exceed the ability of its competition in serving the needs of cancer patients worldwide.
By creating an oncology center of excellence at Millennium, Takeda has enabled it to apply a sole focus on cancer that benefits from a larger pipeline of promising molecules, greater resources for discovery and development, and a bold new vision to become a top three global oncology company by 2020. As Millennium: The Takeda Oncology Company, we're up to that challenge.